MDGL

MADRIGAL PHARMACEUTICALS INC

Healthcare | Large Cap

-$3.73

EPS Forecast

$310.7

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$3.73

Revenue Forecast:

$310.7

EPS Surprise Forecast:

-$0.114

Revenue Surprise Forecast:

$9

Post-release price volatility - High

Post-release Overnight Move:

±8.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

46%

Probability of beating revenue consensus:

76%

Probability of beating both EPS & revs consensus:

41%

Probability of missing both EPS & revs consensus:

18%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

0.44

Earnings volatility

EPS standard deviation:

$1.34

Revenue standard deviation:

$26

As % of share price:

0.30% MEDIUM

As % of market cap:

0.25% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$1.89

Revenue 95th %ile:

$346

EPS 75th %ile:

-$3.24

Revenue 75th %ile:

$320

EPS 25th %ile:

-$4.09

Revenue 25th %ile:

$303

EPS 5th %ile:

-$5.11

Revenue 5th %ile:

$282

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

44% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

53% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$32

Bid-ask per Share:

$1.4